Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1999 2
2002 1
2003 1
2004 4
2006 1
2008 1
2009 1
2011 2
2012 1
2013 3
2014 2
2015 8
2016 7
2017 7
2018 9
2019 10
2020 9
2021 7
2022 16
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial.
Tolaney SM, Tarantino P, Graham N, Tayob N, Parè L, Villacampa G, Dang CT, Yardley DA, Moy B, Marcom PK, Albain KS, Rugo HS, Ellis MJ, Shapira I, Wolff AC, Carey LA, Barroso-Sousa R, Villagrasa P, DeMeo M, DiLullo M, Zanudo JGT, Weiss J, Wagle N, Partridge AH, Waks AG, Hudis CA, Krop IE, Burstein HJ, Prat A, Winer EP. Tolaney SM, et al. Among authors: dang ct. Lancet Oncol. 2023 Mar;24(3):273-285. doi: 10.1016/S1470-2045(23)00051-7. Lancet Oncol. 2023. PMID: 36858723 Clinical Trial.
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.
Tolaney SM, Barry WT, Dang CT, Yardley DA, Moy B, Marcom PK, Albain KS, Rugo HS, Ellis M, Shapira I, Wolff AC, Carey LA, Overmoyer BA, Partridge AH, Guo H, Hudis CA, Krop IE, Burstein HJ, Winer EP. Tolaney SM, et al. Among authors: dang ct. N Engl J Med. 2015 Jan 8;372(2):134-41. doi: 10.1056/NEJMoa1406281. N Engl J Med. 2015. PMID: 25564897 Free PMC article. Clinical Trial.
In Reply.
Dang CT, Singh JC, Steingart RM, Yu AF. Dang CT, et al. Oncologist. 2018 Dec;23(12):e165-e166. doi: 10.1634/theoncologist.2018-0101. Epub 2018 Aug 17. Oncologist. 2018. PMID: 30120162 Free PMC article. No abstract available.
Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
Tolaney SM, Guo H, Pernas S, Barry WT, Dillon DA, Ritterhouse L, Schneider BP, Shen F, Fuhrman K, Baltay M, Dang CT, Yardley DA, Moy B, Marcom PK, Albain KS, Rugo HS, Ellis MJ, Shapira I, Wolff AC, Carey LA, Overmoyer B, Partridge AH, Hudis CA, Krop IE, Burstein HJ, Winer EP. Tolaney SM, et al. Among authors: dang ct. J Clin Oncol. 2019 Aug 1;37(22):1868-1875. doi: 10.1200/JCO.19.00066. Epub 2019 Apr 2. J Clin Oncol. 2019. PMID: 30939096 Free PMC article. Clinical Trial.
Risk-Imaging Mismatch: Why Is There a Disconnect?
Dang CT, Yu AF, Liu J, Steingart R. Dang CT, et al. J Clin Oncol. 2018 Oct 20;36(30):2975-2977. doi: 10.1200/JCO.2018.78.9354. Epub 2018 Aug 31. J Clin Oncol. 2018. PMID: 30169115 No abstract available.
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology).
Blum JL, Flynn PJ, Yothers G, Asmar L, Geyer CE Jr, Jacobs SA, Robert NJ, Hopkins JO, O'Shaughnessy JA, Dang CT, Gómez HL, Fehrenbacher L, Vukelja SJ, Lyss AP, Paul D, Brufsky AM, Jeong JH, Colangelo LH, Swain SM, Mamounas EP, Jones SE, Wolmark N. Blum JL, et al. Among authors: dang ct. J Clin Oncol. 2017 Aug 10;35(23):2647-2655. doi: 10.1200/JCO.2016.71.4147. Epub 2017 Apr 11. J Clin Oncol. 2017. PMID: 28398846 Free PMC article. Clinical Trial.
Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies.
Shamseddine A, Patel SH, Chavez V, Moore ZR, Adnan M, Di Bona M, Li J, Dang CT, Ramanathan LV, Oeffinger KC, Liu JE, Steingart RM, Piersigilli A, Socci ND, Chan AT, Yu AF, Bakhoum SF, Schmitt AM. Shamseddine A, et al. Among authors: dang ct. J Exp Med. 2023 Mar 6;220(3):e20220809. doi: 10.1084/jem.20220809. Epub 2022 Dec 19. J Exp Med. 2023. PMID: 36534085 Free PMC article.
Evolving perspectives on the treatment of HR+/HER2+ metastatic breast cancer.
Pegram M, Pietras R, Dang CT, Murthy R, Bachelot T, Janni W, Sharma P, Hamilton E, Saura C. Pegram M, et al. Among authors: dang ct. Ther Adv Med Oncol. 2023 Aug 11;15:17588359231187201. doi: 10.1177/17588359231187201. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37576607 Free PMC article. Review.
Pheochromocytoma of the organ of Zuckerkandl.
Le HDT, Nguyen TTMH, Pham AV, Dang CT, Nguyen TT. Le HDT, et al. Among authors: dang ct. Radiol Case Rep. 2020 Nov 28;16(2):268-272. doi: 10.1016/j.radcr.2020.11.024. eCollection 2021 Feb. Radiol Case Rep. 2020. PMID: 33299507 Free PMC article.
98 results